Skip to main content

Kerendia

Generic: finerenone

Data may be stale·Apr 23, 2026
NDC
50419-540
RxCUI
2562816
Route
ORAL
ICD-10 indication
E11.22

Affordability Check

How much will you actually pay for Kerendia?

In 30 seconds, see every legitimate way to afford Kerendia — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Kerendia

What is this medication? Kerendia is a prescription drug specifically designed for adults who have chronic kidney disease associated with type 2 diabetes. It is classified as a nonsteroidal mineralocorticoid receptor antagonist, which means it works by blocking certain proteins in the body that can cause inflammation and permanent scarring in the kidneys and heart. By interfering with these harmful processes, the medication helps to preserve kidney function and overall health in patients managing both diabetes and renal issues.

The medication is primarily used to reduce the risk of severe outcomes such as a permanent decline in kidney function, kidney failure, or the need for dialysis. Beyond its benefits for the kidneys, it is also prescribed to lower the risk of cardiovascular death, non-fatal heart attacks, and hospital stays related to heart failure. It is typically used as part of a comprehensive treatment plan that may include other medications and lifestyle changes to manage blood pressure and blood sugar levels.

Copay & patient assistance

  • Patient Copay Amount: As little as $0 per month
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Patients must have commercial (private) insurance. Those enrolled in any government insurance or reimbursement programs (including Medicare, Medicaid, TRICARE, or Veterans Affairs) are not eligible. Full terms and conditions apply.
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Kerendia appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

86%

4,745 of 5,499 plans

Most common tier

Tier 3

On 59% of covering formularies

Prior authorization required

75%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)59
18%
Tier 2 (generic)10
3%
Tier 3 (preferred brand)193
59%
Tier 4 (non-preferred brand)66
20%

Step therapy: 0% of formularies

Quantity limits: 95% of formularies

Coverage breadth: 328 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.